Aquestive therapeutics to participate in leerink partners therapeutics forum: i&i and metabolism

Warren, n.j., june 27, 2024 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (“aquestive” or the “company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the aquestive management team will participate in the leerink partners therapeutics forum: i&i and metabolism and host investor meetings on july 9, 2024. the forum will include panels exploring key therapeutic themes across the fields of immunology and inflammation (i&i) and metabolism.
AQST Ratings Summary
AQST Quant Ranking